Citigroup analyst Steven Enders maintains Asana (NYSE:ASAN) with a Neutral and raises the price target from $23 to $24.
Marinus Pharmaceuticals, Neumora Therapeutics And Other Big Stocks Moving Lower In Monday’s Pre-Market Session
U.S. stock futures were higher this morning, with the Dow futures gaining over 200 points on Monday.